Stage III Inflammatory Breast Cancer Diagnosed After Severe Breast Pain and Swelling Following Mammography

This breast cancer diagnosis at a glance

Stage at diagnosis
Stage IV
Subtype
Inflammatory Breast Cancer
Biomarkers
ER negative, PR negative, HER2 highly positive
Sex
female
Treatment
chemotherapy, targeted therapy, radiation and surgery
Outcome
In Memory

Treatment course, step by step

  1. She received 8 cycles of doxorubicin, cyclophosphamide and docetaxel.
  2. Trastuzumab followed.
  3. She then received 28 radiation treatments.
  4. In October 2009, she underwent mastectomy for a 5 cm inflammatory carcinoma with 2 of 3 nodes involved.
  5. After malignant lesions appeared along the mastectomy scar in 2011, trastuzumab plus vinorelbine produced complete disappearance of the lesions.
  6. A later scar recurrence was surgically removed while the same systemic treatment continued.
  7. After metastatic disease was subsequently found, she chose no further active treatment.

What happened, in summary

A 60-year-old woman underwent a screening mammogram in October 2008 after normal self-examinations and no abnormal findings on the pre-examination check. During compression of the left breast she experienced severe pain. Soon afterward, swelling, bruising and a lump developed and remained painful. Over the following months, the breast mass enlarged rapidly. By February, physical examination measured it at 9 by 11 cm. The cancer was diagnosed as Stage III inflammatory breast carcinoma, with ER and PR negative and strongly HER2-positive disease. She began 8 cycles of doxorubicin, cyclophosphamide and docetaxel, followed by trastuzumab. She also received 28 radiation treatments. Mastectomy in October 2009 showed a 5 cm inflammatory carcinoma with microscopic infiltrating ductal carcinoma, and 2 of 3 lymph nodes contained cancer. In early 2011, malignant lesions appeared along the mastectomy scar. Trastuzumab plus vinorelbine produced complete disappearance of the lesions, but another scar recurrence was later removed while treatment continued. The disease eventually became metastatic. She decided against further active treatment and died of progressive disease in 2012.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories